buprenorphine sublingual Subutex
Selected indexed studies
- Weekly and Monthly Subcutaneous Buprenorphine Depot Formulations vs Daily Sublingual Buprenorphine With Naloxone for Treatment of Opioid Use Disorder: A Randomized Clinical Trial. (JAMA Intern Med, 2018) [PMID:29799968]
- Sublingual buprenorphine. (J Perianesth Nurs, 2010) [PMID:21126674]
- Buprenorphine: clinical pharmacokinetics in the treatment of opioid dependence. (Clin Pharmacokinet, 2005) [PMID:15966752]
_Worker-drafted node — pending editorial review._
Connections
buprenorphine sublingual Subutex is a side effect of
Sources
- Buprenorphine: clinical pharmacokinetics in the treatment of opioid dependence. (2005) pubmed
- Buprenorphine. (1985) pubmed
- Transdermal buprenorphine. (2003) pubmed
- Emergency Department-Initiated Buprenorphine for Opioid Use Disorder: A Randomized Clinical Trial. (2026) pubmed
- Extended-Release Injection vs Sublingual Buprenorphine for Opioid Use Disorder With Fentanyl Use: A Post Hoc Analysis of a Randomized Clinical Trial. (2024) pubmed
- Weekly and Monthly Subcutaneous Buprenorphine Depot Formulations vs Daily Sublingual Buprenorphine With Naloxone for Treatment of Opioid Use Disorder: A Randomized Clinical Trial. (2018) pubmed
- Sublingual buprenorphine. (2010) pubmed
- Sublingual Buprenorphine-Naloxone Exposure and Dental Disease-Reply. (2023) pubmed
- Sublingual Buprenorphine-Naloxone Exposure and Dental Disease. (2023) pubmed
- Buprenorphine initiation strategies for opioid use disorder and pain management: A systematic review. (2022) pubmed